Literature DB >> 35305134

A Systematic Review of the Circadian Rhythm of Bone Markers in Blood.

Sarah Seberg Diemar1, Stig Søgaard Dahl2, Anders Sode West3, Sofie Amalie Simonsen3, Helle Klingenberg Iversen3,4, Niklas Rye Jørgensen5,6,7.   

Abstract

There exists a marked circadian variation for several bone markers (BM), which is influenced by endogenous as well as exogenous factors including hormones, physical activity, and fasting. Consequently, was the aim of this review to provide an overview of the knowledge of the circadian variation of BM and which factors influence this rhythmicity. A systematic search of PubMed was performed for studies evaluating the circadian variation of BM and which factors influence this rhythmicity. The studies were screened for eligibility by a set of predetermined criteria including a list of relevant BM and a minimum study duration of 24 h with at least 3 blood samples of which two should be at least 6 h apart. In total were 29 papers included. There exists a marked circadian variation for most BM including Carboxy-terminal Cross-Linked Telopeptide of Type I Collagen (CTX) and osteocalcin (OC) with nighttime or early morning peak. Pro-collagen Type I N-terminal Propeptide (PINP) and PTH also showed circadian rhythm but with less amplitude. The inter-osteoblast-osteoclast regulatory markers such as OPG, RANKL, FGF23, and sclerostin showed no circadian rhythm. The markers were differently affected by exogenous factors like fasting, which greatly reduced the circadian variation of CTX but did not affect PINP or OC. The marked circadian variation and the factors which influence the rhythmicity, e.g., fasting are of great consequence when measuring BM. To reduce variation and heighten validity should circadian variation and fasting be kept in mind when measuring BM.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bone turnover markers; Carboxy-terminal cross-linked telopeptide of type i collagen; Circadian rhythm; Fibroblast growth factor 23; Osteocalcin; Parathyroid hormone; Pro-collagen type I N-terminal propeptide; Sclerostin

Year:  2022        PMID: 35305134     DOI: 10.1007/s00223-022-00965-1

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  64 in total

Review 1.  Molecular basis and clinical application of biological markers of bone turnover.

Authors:  M S Calvo; D R Eyre; C M Gundberg
Journal:  Endocr Rev       Date:  1996-08       Impact factor: 19.871

Review 2.  An overview of the metabolic functions of osteocalcin.

Authors:  Jianwen Wei; Gerard Karsenty
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

Review 3.  Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL.

Authors:  Emma Harper; Hannah Forde; Colin Davenport; Keith D Rochfort; Diarmuid Smith; Philip M Cummins
Journal:  Vascul Pharmacol       Date:  2016-02-24       Impact factor: 5.773

4.  Changes in bone turnover markers in primary hyperparathyroidism and response to surgery.

Authors:  P Rajeev; A Movseysan; A Baharani
Journal:  Ann R Coll Surg Engl       Date:  2017-09       Impact factor: 1.891

Review 5.  Bone turnover markers and novel biomarkers in lung cancer bone metastases.

Authors:  Jiangli Lang; Qian Zhao; Yuedong He; Xijie Yu
Journal:  Biomarkers       Date:  2018-04-23       Impact factor: 2.658

6.  Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer.

Authors:  I Kanakis; M Nikolaou; D Pectasides; C Kiamouris; N K Karamanos
Journal:  J Pharm Biomed Anal       Date:  2004-03-01       Impact factor: 3.935

Review 7.  The role of osteoprotegerin in cardiovascular disease.

Authors:  Martina Montagnana; Giuseppe Lippi; Elisa Danese; Gian Cesare Guidi
Journal:  Ann Med       Date:  2012-10-30       Impact factor: 4.709

Review 8.  Osteocalcin: skeletal and extra-skeletal effects.

Authors:  Anna Neve; Addolorata Corrado; Francesco Paolo Cantatore
Journal:  J Cell Physiol       Date:  2013-06       Impact factor: 6.384

9.  International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.

Authors:  Samuel Vasikaran; Cyrus Cooper; Richard Eastell; Andrea Griesmacher; Howard A Morris; Tommaso Trenti; John A Kanis
Journal:  Clin Chem Lab Med       Date:  2011-05-24       Impact factor: 3.694

10.  Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients.

Authors:  Sun Min Lim; Youn Nam Kim; Ki Hyun Park; Beodeul Kang; Hong Jae Chon; Chan Kim; Joo Hoon Kim; Sun Young Rha
Journal:  BMC Cancer       Date:  2016-07-04       Impact factor: 4.430

View more
  2 in total

1.  Acute Effects of Strength and Endurance Training on Bone Turnover Markers in Young Adults and Elderly Men.

Authors:  Astrid Kamilla Stunes; Cathrine Langlie Brobakken; Md Abu Jafar Sujan; Norun Aagård; Martin Siksjø Brevig; Eivind Wang; Unni Syversen; Mats Peder Mosti
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-30       Impact factor: 6.055

2.  Circadian rhythm of markers of bone turnover in patients with chronic kidney disease.

Authors:  D Hansen; I Bressendorff; A Nordholm; A A Jacobsen; T W Klausen; N R Jørgensen
Journal:  Bone Rep       Date:  2022-05-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.